4//SEC Filing
Salmon Sean 4
Accession 0001613103-24-000092
CIK 0001613103other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 8:03 PM ET
Size
10.0 KB
Accession
0001613103-24-000092
Insider Transaction Report
Form 4
Salmon Sean
EVP & Group President Diabetes
Transactions
- Award
Ordinary Shares
2024-07-29+14,375→ 63,084 total - Award
Stock Option (Right to Buy)
2024-07-29+106,260→ 106,260 totalExercise: $80.00Exp: 2034-07-29→ Ordinary Shares (106,260 underlying) - Award
Performance Share Unit
2024-07-29+35,938→ 35,938 total→ Performance Share Units (35,938 underlying)
Footnotes (6)
- [F1]The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
- [F2]Includes 420 shares acquired through dividend reinvestment since the last report filed by the reporting person.
- [F3]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- [F4]Vests on July 29, 2027.
- [F5]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 35,938 shares will be issued. If maximum performance metrics are achieved, 71,876 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- [F6]These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Documents
Issuer
Medtronic plc
CIK 0001613103
Entity typeother
Related Parties
1- filerCIK 0001792380
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 8:03 PM ET
- Size
- 10.0 KB